Mednax Inc Stock Fundamentals
| MD Stock | USD 14.75 0.26 1.79% |
Mednax Inc fundamentals help investors to digest information that contributes to Mednax's financial success or failures. It also enables traders to predict the movement of Mednax Stock. The fundamental analysis module provides a way to measure Mednax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mednax stock.
At present, Mednax's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 69.6 M, whereas Interest Expense is forecasted to decline to about 24.4 M. Mednax | Select Account or Indicator |
Mednax Inc Company Return On Asset Analysis
Mednax's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mednax Return On Asset | 0.0467 |
Most of Mednax's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mednax Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Mednax Total Assets
Total Assets |
|
Based on the latest financial disclosure, Mednax Inc has a Return On Asset of 0.0467. This is 100.53% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 133.36% lower than that of the firm.
Mednax Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mednax's current stock value. Our valuation model uses many indicators to compare Mednax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mednax competition to find correlations between indicators driving Mednax's intrinsic value. More Info.Mednax Inc is rated below average in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . At present, Mednax's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Mednax by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Mednax Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednax's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mednax could also be used in its relative valuation, which is a method of valuing Mednax by comparing valuation metrics of similar companies.Mednax is currently under evaluation in return on asset category among its peers.
Mednax ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mednax's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mednax's managers, analysts, and investors.Environmental | Governance | Social |
Mednax Fundamentals
| Return On Equity | -0.3 | ||||
| Return On Asset | 0.0467 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 1.71 B | ||||
| Shares Outstanding | 85.88 M | ||||
| Shares Owned By Insiders | 1.67 % | ||||
| Shares Owned By Institutions | 98.33 % | ||||
| Number Of Shares Shorted | 3.94 M | ||||
| Price To Earning | 89.39 X | ||||
| Price To Book | 1.70 X | ||||
| Price To Sales | 0.62 X | ||||
| Revenue | 1.99 B | ||||
| Gross Profit | 467.03 M | ||||
| EBITDA | 29.89 M | ||||
| Net Income | (60.41 M) | ||||
| Cash And Equivalents | 9.82 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 701.65 M | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 8.67 X | ||||
| Cash Flow From Operations | 137.32 M | ||||
| Short Ratio | 7.04 X | ||||
| Earnings Per Share | (2.34) X | ||||
| Price To Earnings To Growth | 0.88 X | ||||
| Target Price | 15.92 | ||||
| Number Of Employees | 5.45 K | ||||
| Beta | 1.56 | ||||
| Market Capitalization | 1.24 B | ||||
| Total Asset | 2.22 B | ||||
| Retained Earnings | (149.47 M) | ||||
| Working Capital | 94.51 M | ||||
| Current Asset | 527.77 M | ||||
| Current Liabilities | 428.77 M | ||||
| Net Asset | 2.22 B |
About Mednax Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mednax Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednax Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -32.4 M | -34.1 M | |
| Total Revenue | 2 B | 1.5 B | |
| Cost Of Revenue | 1.6 B | 977.3 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.11 | 0.11 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 23.74 | 11.99 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Mednax Piotroski F Score and Mednax Altman Z Score analysis. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (2.34) | Revenue Per Share 24.174 | Quarterly Revenue Growth 0.009 | Return On Assets 0.0467 |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.